Delcath Systems has appointed J. Chris Houchins to the company's clinical development team as senior vice president, clinical and medical affairs.

Houchins will be responsible for the development and implementation of clinical trial strategies for Delcath’s proprietary chemosaturation system and the development and management of relationships with medical societies, thought leaders, advocacy organizations, academic institutions and health plans.

Houchins has over 21 years of experience in leading the global development and implementation of clinical, medical and scientific operations in oncology. He most recently was COO and senior vice president of clinical operations for Arno Therapeutics, an oncology-focused biopharmaceutical company. Houchins has held director of operations positions at Schering-Plough and Pfizer.